Page 115 - 《中国药房》2026年3期
P. 115

·智慧药学·


          基于季节性Mann-Kendall趋势检验的药品用量动态监测研究                                                             Δ


                *
                                               #
          余子珩 ,陈 辰,杨香瑜,李璐璐,张韶辉(武汉市第一医院药学部,武汉 430022)
          中图分类号  R952      文献标志码  A      文章编号  1001-0408(2026)03-0377-06
          DOI  10.6039/j.issn.1001-0408.2026.03.18

          摘  要  目的  探索构建基于季节性Mann-Kendall趋势检验的药品用量动态监测(DMDC)模型,为高效、宏观地监测药品使用提
          供科学依据。方法  基于2024年10月门诊药房销售额排名前20%的药品建立门诊重点药物监控目录。以门诊重点药物2021年
          11月-2024年10月的月度用量数据建立Mann-Kendall趋势检验的DMDC模型,消除季节性波动的影响,分析药品用量随时间的
          变化趋势。以黏液溶解性祛痰药、皮肤真菌病用三唑类衍生物、单方羟甲基戊二酸单酰辅酶A(HMG-CoA)还原酶抑制剂为例,展
          示DMDC模型的监测效果,并与传统的环比增长率排序法的监测效能进行比较。结果  门诊重点药物监控目录共纳入215个品
          种,其均成功建立DMDC模型。其中,具有显著上升趋势的品种119个(P<0.05,S′>0)。所建模型成功监测了黏液溶解性祛痰
          药、皮肤真菌病用三唑类衍生物、单方HMG-CoA还原酶抑制剂等药品的月度用量。DMDC模型识别潜在异动药品的精确率和召
          回率分别为 60.7%、85.0%,均显著高于环比增长率排序法(8.3%、15.0%)(χ =20.114,P<0.001;χ =19.600,P<0.001)。结论  基
                                                                   2
                                                                                    2
          于季节性Mann-Kendall趋势检验的DMDC模型能够有效识别药品用量的长期趋势,排除季节性干扰,提升监测精准性与管理效
          率,适用于对药品用量进行动态监测。
          关键词  药品用量;动态监测;季节性Mann-Kendall趋势检验;季节性波动

          Research on dynamic monitoring of drug consumption based on seasonal Mann-Kendall trend test
          YU Ziheng,CHEN Chen,YANG Xiangyu,LI Lulu,ZHANG Shaohui(Dept.  of  Pharmacy,  Wuhan  No. 1
          Hospital, Wuhan 430022, China)

          ABSTRACT   OBJECTIVE  To  investigate  a  dynamic  monitoring  of  drug  consumption (DMDC)  model  based  on  the  seasonal
          Mann-Kendall  trend  test,  aiming  to  provide  scientific  evidence  for  the  efficient  and  macroscopic  monitoring  of  drug  use.
          METHODS A monitoring list of key outpatient drugs was established based on the top 20% of drugs ranked by sales volume in the
          outpatient  pharmacy  in  October  2024. A  DMDC  model  based  on  the  Mann-Kendall  trend  test  was  constructed  using  the  monthly
          usage  data  of  key  outpatient  drugs  from  November  2021  to  October  2024,  aiming  to  eliminate  the  impact  of  seasonal  fluctuations
          and analyze the temporal trends in drug consumption. Taking mucolytic expectorants, triazole derivatives for dermatophytosis, and
          single-agent hydroxymethylglutaryl coenzyme A (HMG-CoA) reductase inhibitors as examples, the monitoring effectiveness of the
          DMDC  model  was  demonstrated,  and  its  performance  was  compared  with  that  achieved  by  the  traditional  sequential  growth  rate
          ranking  method.  RESULTS  A  total  of  215  drug  varieties  were  included  in  the  monitoring  list,  and  DMDC  models  were
          successfully  established  for  all  of  them.  Among  these,  119  showed  a  significant  increasing  trend (P<0.05,  S′>0).  The  model
          successfully  monitored  the  monthly  consumption  of  mucolytic  expectorants,  triazole  derivatives  for  dermatophytosis,  and  single-
          agent  HMG-CoA  reductase  inhibitors.  The  precision  and  recall  rates  of  the  DMDC  model  for  identifying  abnormal  drug  use  were
          60.7%  and  85.0%,  respectively,  both  significantly  higher  than  those  of  the  sequential  growth  rate  ranking  method (8.3%  and
          15.0%,  respectively) (χ =20.114,  P<0.001;  χ =19.600,  P<0.001).  CONCLUSIONS  DMDC  model  based  on  the  seasonal
                                               2
                            2
          Mann-Kendall  trend  test  can  effectively  identify  long-term  trends  in  drug  consumption,  eliminate  seasonal  interference,  enhance
          monitoring accuracy and management efficiency, and is suitable for the dynamic monitoring of drug consumption.
          KEYWORDS    drug consumption; dynamic monitoring; seasonal Mann-Kendall trend test; seasonal fluctuations


                                                                 随着门诊统筹和医疗大数据的发展,医院药品使用

             Δ 基金项目 武汉市卫生健康委课题(No.S202406050039)             动态监测与预警已经成为医院药事管理的重要组成部
             *第一作者 中药师,硕士。研究方向:医院药学、天然药物化学。                  分,其在保障药品合理使用、健全药品供应等环节上为
          E-mail:yuziheng0728@163.com
                                                                                  [1]
                                                             患者健康权益提供支撑 。国家卫生健康委在《关于开
             # 通信作者 副主任药师,博士。研究方向:临床药学、医院药学。
          E-mail:zshtjmu@hotmail.com                         展药品使用监测与临床综合评价工作的通知》中指明了

          中国药房  2026年第37卷第3期                                                 China Pharmacy  2026 Vol. 37  No. 3    · 377 ·
   110   111   112   113   114   115   116   117   118   119   120